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Background
Different genes are involved in the pathogenesis of acute
and chronic hepatitis B virus (HBV) infection, although
little is known about these genes.
Materials and methods
A full length HBV genome was cloned and sequenced
from serum of a chronic hepatitis B (CHB) patient. The
genome and sterilized Milli-Q water were transfected to
HepG2 and HepG2.2.15 cells, respectively, by lipo-
fectamine 2000. The prior cell line was named
HepG29BL. The two cell lines were collected post transfec-
tion 48 hours. Differential genes were examined using
Affy Human U133 2.0A gene chip; Real time polymerase
chain (RT-PCR) was performed to confirm the expression
of lumican in six human hepatoma carcinoma cell lines.
Results
Of 50,000 transcripts and variants on the gene chip, 4860
genes were significantly altered between the two cell lines.
Pro-inflammatory and interferon associated molecules
(e.g, IL-6, IFNAR2, IFNA17, etc.) were up regulated in
HepG29BL, while down regulated in HepG2.2.15. The
ratio of lumican was significantly high between the two
cell lines. The levels of lumican were showed in six cell
lines as follows: HepG29BL> HepG2>7402> Alexan-
der>MHCC-97 >HepG2.2.15 (P < 0.05, but the compar-
sion between MHCC-97 and HepG2.2.15 was not
statistically significant).
Conclusion
The result of this study provides a foundation for future
investigations of genes involved in the pathogenesis of
HBV infection. Lumican, as reported in CHB [1] and in
other organs cancer pathogenesis study [2], may play an
role in liver fibrosis and carcinogenesis.
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